New treatment option for Intracerebral Haemorrhage (ICH)
Official title Surgical Evacuation Of Spontaneous Intracerebral Hematoma: Clinical Outcomes and Prognostic Factors
ClinicalTrials.gov ID: NCT06816641
What this study is testing
- What it's testing
- The aim of this study is to assess the safety and efficacy of surgical evacuation of spontaneous intracerebral hemorrhage.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 70
You may be able to join if
- Patients with radiological findings of ICH.
- Age group 20-70 years.
You likely can't join if
- Traumatic ICH or ruptured aneurysm or AVM or brain tumor.
- Postoperative cranial surgery ICH.
- Secondary hydrocephalus.
- Patients with other comorbidities e.g., Liver cell failure and renal cell failure.
- Patients with bleeding disorders.
- Patients who are regular on anticoagulant or antiplatelet therapy.
See the full eligibility criteria
- Patients with radiological findings of ICH.
- Age group 20-70 years.
- Traumatic ICH or ruptured aneurysm or AVM or brain tumor.
- Postoperative cranial surgery ICH.
- Secondary hydrocephalus.
- Patients with other comorbidities e.g., Liver cell failure and renal cell failure.
- Patients with bleeding disorders.
- Patients who are regular on anticoagulant or antiplatelet therapy.
- Small sized ICH\< 30 ml.
- GCS less than 6 preoperatively.
The study team makes the final eligibility decision.
Where it's taking place
- Sohag, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Sohag, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.